Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. 2001

L K Heilbronn, and M Noakes, and P M Clifton
Department of Physiology, Adelaide University, Adelaide, South Australia. leonie.heilbronn@hsn.csiro.au

C-reactive protein (CRP) is an inflammatory-response protein that is a strong, independent predictor of cardiovascular mortality. CRP is positively associated with body mass index (BMI). In this study, we investigated the effects of dynamic weight loss on CRP in 83 healthy, obese women (mean BMI, 33.8+/-0.4 kg/m(2); range, 28.2 to 43.8 kg/m(2)). Subjects were placed on very-low-fat, energy-restricted diets (5700 kJ, 15% fat) for 12 weeks. Weight, waist and hip circumferences, plasma lipids, glucose, and CRP were measured at baseline and after 12 weeks. CRP was positively associated with BMI (r=0.281, P=0.01) and waist circumference (r=0.278, P=0.01) but was not related to other atherosclerosis risk factors. BMI was significantly different between groups split above or below the median for CRP (34.8+/-0.6 kg/m(2) vs 33.0+/-0.5 kg/m(2), P=0.02). After 12 weeks, weight loss was 7.9+/-0.3 kg. CRP was significantly decreased by 26% (P<0.001), and a correlation was observed between weight loss and the change in CRP (r=0.309, P=0.005). The variance in the change in CRP was partly explained by initial CRP (13.6%), energy intake (5.4%), and percentage weight loss (4.6%, P=0.001). This study confirms recent observations that BMI is associated with CRP, a marker for low-grade systemic inflammation. Furthermore, we observed that CRP was lowered in proportion to weight loss.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001824 Body Constitution The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms. Body Constitutions,Constitution, Body,Constitutions, Body
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D018752 Diet, Fat-Restricted A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIAS. (From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed) Diet, Fat-Free,Diet, Low-Fat,Fat-Restricted Diet,Diet, Fat Free,Diet, Fat Restricted,Diet, Low Fat,Diets, Fat-Free,Diets, Fat-Restricted,Diets, Low-Fat,Fat Restricted Diet,Fat-Free Diet,Fat-Free Diets,Fat-Restricted Diets,Low-Fat Diet,Low-Fat Diets

Related Publications

L K Heilbronn, and M Noakes, and P M Clifton
March 2005, The Journal of clinical endocrinology and metabolism,
L K Heilbronn, and M Noakes, and P M Clifton
February 2002, Circulation,
L K Heilbronn, and M Noakes, and P M Clifton
July 1992, The American journal of clinical nutrition,
L K Heilbronn, and M Noakes, and P M Clifton
July 1992, The American journal of clinical nutrition,
L K Heilbronn, and M Noakes, and P M Clifton
December 2007, Obesity research & clinical practice,
L K Heilbronn, and M Noakes, and P M Clifton
August 2011, Metabolic syndrome and related disorders,
L K Heilbronn, and M Noakes, and P M Clifton
April 2007, Journal of the American College of Nutrition,
L K Heilbronn, and M Noakes, and P M Clifton
October 1994, The American journal of clinical nutrition,
L K Heilbronn, and M Noakes, and P M Clifton
January 2010, The British journal of nutrition,
Copied contents to your clipboard!